首页> 外文OA文献 >No increase of leukemia relapse in newly diagnosed patients with acute myeloid leukemia who received granulocyte colony-stimulating factor for life-threatening infection during remission induction and consolidation therapy. Japan Adult Leukemia Study Group letter

【2h】

No increase of leukemia relapse in newly diagnosed patients with acute myeloid leukemia who received granulocyte colony-stimulating factor for life-threatening infection during remission induction and consolidation therapy. Japan Adult Leukemia Study Group letter

机译：Neuce患有急性髓性白血病患者的白血病复发没有增加，他在缓解诱导和固结疗法期间接受了造粒细胞菌落刺激因子的粒状菌落刺激因子。日本成人白血病研究组信

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
R Ohno; A Hiraoka; M Tanimoto; N Asou; K Kuriyama; T Kobayashi; M Yoshida; H Teshima; H Saito; K Fujimoto;
展开▼
作者单位

展开▼
年度 1993
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Effect of priming with granulocyte|[ndash]|macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group [J] . X Thomas, E Raffoux, S de Botton, Leukemia . 2007,第3期

机译：粒细胞刺激巨噬细胞集落刺激因子对新诊断的急性髓性白血病的年轻成年人的作用：法国急性白血病协会（ALFA）的一项试验
2. Complete Remission Following Chemotherapy with Low-dose Cytosine Arabinoside and Macrophage Colony-stimulating Factor/Granulocyte Colony-stimulating Factor in a Patient with Relapsed Acute Myeloid Leukemia after Stem Cell Transplantation [J] . Kohei Okada, Asumi Higashiyama, Mutsumi Takahata, Internal medicine. . 2013,第20期

机译：干细胞移植术后复发性急性髓细胞白血病患者接受低剂量胞嘧啶核糖苷和巨噬细胞集落刺激因子/粒细胞集落刺激因子化疗后完全缓解
3. Complete Remission Following Chemotherapy with Low-dose Cytosine Arabinoside and Macrophage Colony-stimulating Factor/Granulocyte Colony-stimulating Factor in a Patient with Relapsed Acute Myeloid Leukemia after Stem Cell Transplantation [J] . Kohei Okada, Asumi Higashiyama, Mutsumi Takahata, Internal medicine. . 2012,第20期

机译：干细胞移植术后复发性急性髓细胞白血病患者接受低剂量胞嘧啶核糖苷和巨噬细胞集落刺激因子/粒细胞集落刺激因子化疗后完全缓解
4. Identification of Platelet Factor-4 as an Indicator of Blood Count Recovery in Acute Myeloid Leukemia Patients in Complete Remission [C] . Jin Young Kim, Ho-Jun Song, Hoi-Jeong Lim, ASMS Conference on Mass Spectrometry and Allied Topics . 2008

机译：血小板因子-4的鉴定为急性髓性白血病患者血统恢复的指标完全缓解
5. Prognostic analysis according to the 2017 ELN risk stratification by genetics in adult acute myeloid leukemia patients treated in the Japan Adult Leukemia Study Group (JALSG) AML201 study [D] . Harada Yasuhiko, 原田靖彦 2019

机译：根据2017年日本成人白血病研究组（JALSG）AML201研究治疗的成人急性髓性白血病患者的遗传学预测，根据2017 ELN风险分层进行预后分析
6. Clinical efficacy of decitabine in combination with standard-dose cytarabine aclarubicin hydrochloride and granulocyte colony-stimulating factor in the treatment of young patients with newly diagnosed acute myeloid leukemia [O] . Liping Dou, Qingyu Xu, Mengzhen Wang, 2019

机译：地西他滨联合标准剂量阿糖胞苷盐酸阿克拉比星和粒细胞集落刺激因子联合治疗新诊断为急性髓性白血病的年轻患者的临床疗效
7. Use of recombinant granulocyte-macrophage colony-stimulating factor during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia (AML): final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the research and treatment of cancer (EORTC-LCG) and the Dutch Belgian Hemato-Oncology Cooperative Group (HOVON) [O] . Lowenberg B., Suciu S., Archimbaud E., 1997

机译：重组粒细胞巨噬细胞集落刺激因子在61岁及以上急性髓样白血病（AML）患者缓解诱导化疗期间和之后的应用：AML-11的最终报告，这是欧洲白血病合作小组进行的一项III期随机研究癌症研究和治疗组织（EORTC-LCG）和荷兰比利时血液肿瘤合作组（HOVON）

No increase of leukemia relapse in newly diagnosed patients with acute myeloid leukemia who received granulocyte colony-stimulating factor for life-threatening infection during remission induction and consolidation therapy. Japan Adult Leukemia Study Group letter

著录项

相似文献

相关主题

期刊订阅